Location History:
- Albany, NY (US) (2004 - 2011)
- Defreestville, NY (US) (2008 - 2012)
Company Filing History:
Years Active: 2004-2012
Title: Innovations in HIV Research by Sean Philpott
Introduction
Sean Philpott is an accomplished inventor based in Defreestville, NY (US), known for his significant contributions to the field of HIV research. With a total of seven patents to his name, Philpott has focused on developing diagnostic methods that enhance the clinical management of HIV infection. His work is crucial in understanding viral tropism and improving patient outcomes.
Latest Patents
Philpott's latest patents include innovative diagnostic methods such as the Heteroduplex Tracking Assay. This method addresses the change in viral tropism that occurs in many HIV-positive individuals over time, particularly the shift in coreceptor use from CCR5 to CXCR4. This shift has been correlated with increased disease progression. His invention provides a diagnostic method to monitor coreceptor use in the treatment of HIV infection, especially for patients undergoing Highly Active Antiretroviral Therapy (HAART). The methods he developed can assist in selecting appropriate antiretroviral therapy and improve predictions of disease prognosis over time.
Career Highlights
Philpott's career is marked by his dedication to advancing HIV research through innovative diagnostic techniques. His work has been instrumental in providing healthcare professionals with tools to better manage HIV-positive patients. The impact of his inventions is significant, as they contribute to improved patient care and treatment strategies.
Collaborations
Philpott collaborates with notable colleagues such as Barbara Weiser and Harold Burger, enhancing the research efforts at Health Research, Inc. Their combined expertise fosters an environment of innovation and progress in the field of HIV research.
Conclusion
Sean Philpott's contributions to HIV research through his patents and collaborative efforts have made a lasting impact on the clinical management of the disease. His innovative approaches continue to pave the way for advancements in patient care and treatment options.